#drug-pricing
(7 articles)US Launches Section 301 Probe Into German Drug Pricing
The U.S. Trade Representative has initiated a Section 301 investigation into Germany's drug pricing policies, alleging that the European nation's regulatory framework unfairly shifts pharmaceutical re
Tariffs and Geopolitics Reshape Pharma Supply Chains
The pharmaceutical industry faces unprecedented pressure as tariff escalations and geopolitical fragmentation fundamentally alter how companies source ingredients, manufacture drugs, and distribute pr
US Tariffs on Pharma Threaten Drug Costs and Global Supply
US tariff policies targeting pharmaceutical imports present a critical structural challenge to global drug supply chains and patient access. The pharmaceutical industry relies heavily on cross-border
Trump's Drug Tariffs Force Pharma Supply Chain Rethink
The Trump administration's proposed tariffs on pharmaceuticals represent a structural shift in how the industry sources active pharmaceutical ingredients and finished drugs, potentially forcing manufa
Tariffs and Geopolitics Reshape Pharma Supply Chains
The pharmaceutical industry faces a critical inflection point as trade policy uncertainty and geopolitical tension force fundamental restructuring of global sourcing and distribution networks. Tariff
100% Pharma Tariffs: Supply Chain & Manufacturing Impact
A proposed 100% tariff regime on pharmaceutical imports represents a structural shift in U.S. trade policy with far-reaching consequences for the pharmaceutical supply chain. This development reflects
Tariffs and Geopolitical Tension Disrupt Pharma Supply Chains
Global pharmaceutical supply chains face unprecedented structural pressure from converging tariff regimes and geopolitical instability. Trade barriers, particularly between major economies, are forcin